4//SEC Filing
Hanlon Suzanne M. 4
Accession 0001192482-19-000051
CIK 0001621443other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:20 PM ET
Size
5.4 KB
Accession
0001192482-19-000051
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Stock Option (right to buy)
2019-01-24+52,859→ 52,859 totalExercise: $3.65Exp: 2029-01-24→ Common Stock (52,859 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company.
Documents
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
Related Parties
1- filerCIK 0001631682
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:20 PM ET
- Size
- 5.4 KB